GSK840
GSK840 (GSK'840) is a receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds RIP3 kinase domain with an IC50 of 0.9 nM, and inhibits kinase activity with an IC50 of 0.3 nM[1].
Product Specifications
CAS Number
[2361146-30-5]
Product Name Alternative
GSK'840
UNSPSC
12352005
Target
RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/gsk840.html
Purity
99.95
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(OC(C)(C)C)CC1=CC=C(N2C3=CC=C(C(NC)=O)C=C3N=C2)C=C1
Molecular Formula
C21H23N3O3
Molecular Weight
365.43
References & Citations
[1]Mandal P, et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell. 2014 Nov 20;56 (4) :481-95.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RIPK3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC212931L3V 200 µL
Macrophage Scavenger Receptor I (MSR1) (NM_002445) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 
MBS6223715-01 0.1 mL
PCLKC (Cadherin-related Family Member 2, Protocadherin LKC, PC-LKC, Protocadherin-24, PCDH24, PCLKC, FLJ20124, FLJ20383, MGC163154) (MaxLight 650)
Ask
View Details 
MBS6223715-02 5x 0.1 mL
PCLKC (Cadherin-related Family Member 2, Protocadherin LKC, PC-LKC, Protocadherin-24, PCDH24, PCLKC, FLJ20124, FLJ20383, MGC163154) (MaxLight 650)
Ask
View Details